After confirming that high expression of VEGF may be a potential contributor to IDD, we assessed whether bevacizumab, a specific small molecule inhibitor of VEGF, could inhibit or repair degeneration in NP cells by inhibiting VEGF expression. The gene discussed is VEGFA; the disease is intervertebral disk degenerative disorder.